This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity.  We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.


At present, screening of the population at risk for gambiense human African trypanosomiasis (HAT) is based on detection of antibodies against naive variant surfance glycoproteins (VSGs) of Trypanosoma brucei (T.b.) gambiense. Drawbacks of these native VSGs include culture of infective T.b gambiense trypanosomes in laboratory rodents, necessary for production, and the exposure of non-specific epitopes that may cause cross-reactions. We therefore aimed at identifying peptides that mimic epitopes, hence called 'mimotopes', specific to T.b. gambiense VSGs and that may resplace the native proteins in antibody detection tests.

The article presenting this research has been published in PLoS Neglected Tropical Diseases and is available here.

Also By

Liesbeth Van Nieuwenhove, Philippe Buscher, Fatima Balharbi, Michael Humbert, Tessa Dieltjens, Yves Guisez, Veerle Lejon